In brief

Oncoclínicas expanded its out-of-court restructuring to R$ 5.7 billion.

The plan includes payment in shares.

What we know

04
  1. Verified fact · material

    Oncoclínicas presented a new out-of-court restructuring plan covering about R$ 5.7 billion in debt, disclosed in a material fact.

    Plan.

    Sources[01][02]
  2. Verified fact · material

    The plan includes swaps into new instruments, longer maturities, convertible debentures, payment in shares and discounts.

    Measures.

    Sources[01][02]
  3. Verified fact

    According to Investidor10, the plan needs support from creditors holding 51% of claims.

    Quorum.

    Sources[01]
  4. Verified fact

    According to Money Times, the plan covers unsecured debt, excluding intragroup debt.

    Scope.

    Sources[02]

Transmission to assets

Market read-through

Conversion into shares may dilute minority holders, and creditor support is not yet secured.

Portfolio impact

01
ONCO3uncertain

Equity conversion dilutes holders.

Creditors reject.

What would change the view: High support.

direct20% confidence

Direction is an explanatory hypothesis, not a forecast or recommendation.

Next signals

What to watch

  • Creditor support
  • Court approval

Limits of the reporting

What remains uncertain

  • Sources differ on the month of the previous plan.

Full sources

02